Ping‐Chih Hsu

YAP regulates PD-L1 expression in human NSCLC cells

Jinbai Miao, Ping‐Chih Hsu, Yi‐Lin Yang et al. · Oncotarget · 2017 · 130 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

YAP promotes erlotinib resistance in human non-small cell lung cancer cells

Ping‐Chih Hsu, Bin You, Yi‐Lin Yang et al. · Oncotarget · 2016 · 116 citations · Full text

Medicine, Oncology, Pharmacology +17

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim et al. · Journal of Clinical Oncology · 2024 · 114 citations · Full text

Medicine, Oncology, Pharmacology +16

Inhibition of yes‐associated protein down‐regulates PD‐L1 (CD274) expression in human malignant pleural mesothelioma

Ping‐Chih Hsu, Jinbai Miao, Yucheng Wang et al. · Journal of Cellular and Molecular Medicine · 2018 · 62 citations · Full text

Medicine, Cancer Biology, Oncology +17

Targeting YAP in malignant pleural mesothelioma

Wenqian Zhang, Yuyuan Dai, Ping‐Chih Hsu et al. · Journal of Cellular and Molecular Medicine · 2017 · 58 citations · Full text

Medicine, Cancer Biology, Oncology +15